Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
Aitana Sogorb‐Esteve, Johanna Nilsson, Imogen J. Swift, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 19

Showing 19 citing articles:

Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
Shreyasee Das, Julie Goossens, Dirk Jacobs, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases
Sára Mravinacová, Sofia Bergström, Jennie Olofsson, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
Megi Meneri, Elena Abati, Delia Gagliardi, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1254-1254
Open Access | Times Cited: 16
Emerging perspectives of synaptic biomarkers in ALS and FTD
Karrthik Krishnamurthy, Raj Kumar Pradhan
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 6
Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives
Simone Lista, Alejandro Santos‐Lozano, Enzo Emanuele, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 847-857
Closed Access | Times Cited: 5
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Shreyasee Das, Marie‐Paule E. van Engelen, Julie Goossens, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes
Aitana Sogorb‐Esteve, Sophia Weiner, Joel Simrén, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 784
Closed Access
NPTX2 transfection improves synaptic E/I balance and performance in learning impaired aged rats
Daniel Severín, Ming Teng Koh, Cristian Moreno, et al.
Progress in Neurobiology (2025), pp. 102746-102746
Closed Access
Biomarkers in frontotemporal dementia: Current landscape and future directions
Abbott Gifford, Nathan Praschan, Amy Newhouse, et al.
Biomarkers in Neuropsychiatry (2023) Vol. 8, pp. 100065-100065
Open Access | Times Cited: 12
Cerebrospinal fluid synaptic biomarker changes in bipolar disorder – A longitudinal case-control study
Ulla Knorr, Anja Hviid Simonsen, Johanna Nilsson, et al.
Journal of Affective Disorders (2024) Vol. 358, pp. 250-259
Open Access | Times Cited: 3
Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma
Takahiro Shinozuka, Mitsuro Kanda, Yusuke Sato, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 3
Exploring Temporal and Sex-Linked Dysregulation in Alzheimer's Disease Phospho-Proteome
Serhan Yılmaz, Filipa Blasco Tavares Pereira Lopes, Daniela Schlatzer, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 110941-110941
Open Access | Times Cited: 2
Frontotemporal dementia
Shaimaa Nasr Amin, Ahmed Bassam Mohd, Carla Ammar Samain, et al.
Elsevier eBooks (2024), pp. 131-146
Closed Access | Times Cited: 2
Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia
Chiara Fenoglio, María Serpente, Caterina Visconte, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14723-14723
Open Access | Times Cited: 7
Altered plasma protein profiles in genetic FTD – a GENFI study
Abbe Ullgren, Linn Öijerstedt, Jennie Olofsson, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Addressing inter-individual variability in CSF levels of brain-derived proteins across neurodegenerative diseases
Sára Mravinacová, Sofia Bergström, Jennie Olofsson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia
Yanaika S. Hok‐A‐Hin, Lisa Vermunt, Carel F.W. Peeters, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer’s disease in cerebrospinal fluid
Xiaosen Hou, Zhenzhen Quan, Ailikemu Aierken, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
An interventional study of baicalin on neuronal pentraxin-1, neuronal pentraxin-2, and C-reactive protein in Alzheimer’s disease rat model
Jingkun Zhao, Si-Jia Hou, Jiwei Zhao, et al.
Translational Neuroscience (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top